Loading…
Statistical Comparison of DCE-MRI Pharmacokinetic Models in Human Breast Cancer
By fitting dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) data to an appropriate pharmacokinetic model, quantitative physiological parameters can be estimated. In this study, we compare four different models by applying four statistical measures to assess their ability to describe DC...
Saved in:
Published in: | Magnetic resonance in medicine 2011-11, Vol.68 (1), p.261-271 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | By fitting dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) data to an appropriate pharmacokinetic model, quantitative physiological parameters can be estimated. In this study, we compare four different models by applying four statistical measures to assess their ability to describe DCE-MRI data obtained in 28 human breast cancer patient sets: the chi-square test (χ
2
), Durbin-Watson statistic (DW), Akaike Information Criteria (AIC), and Bayesian Information Criterion (BIC). The pharmacokinetic models include: the fast exchange limit model with (FXL_
v
p
) and without (FXL) a plasma component, and the fast and slow exchange regime models (FXR and SXR, respectively). The results show that the FXL_
v
p
and FXR models yielded the smallest χ
2
in 45.64% and 47.53% of the voxels, respectively; they also had the smallest number of voxels showing serial correlation with 0.71% and 2.33%, respectively. The AIC indicated that the FXL_
v
p
and FXR models were preferred in 42.84% and 46.59% of the voxels, respectively. The BIC also indicated the FXL_
v
p
and FXR models were preferred in 39.39% and 45.25% of the voxels, respectively. Thus, these four metrics indicate that the FXL_
v
p
and the FXR models provide the most complete statistical description of DCE-MRI time courses for the patients selected in this study. |
---|---|
ISSN: | 0740-3194 1522-2594 |
DOI: | 10.1002/mrm.23205 |